Venture capital firms help health data sharing startup Human API to Series C success

133

Human API, which is helping consumers to connect and share electronic health data with companies, has bagged $20m in its Series C.

The investment saw contributions from Samsung Ventures, CNO Financial Group, Allianz Life Ventures and Moneta VC. Several existing Human API backers also joined the round, including BlueRun Ventures, SCOR Life and Health Ventures, and Guardian Life Insurance Company.

Capital from the round will be used to scale new products and services that enable product design, granular risk stratification, optimise clinical trial recruitment, support population health management, automate patient monitoring and digitise chronic disease management.

The funding will also help the InsurTech to build momentum within the insurance, pharma and digital health industries.

Human API founder and CEO Andrei Pop said, “With this new capital we’re evolving Human API into a digital transformation platform unifying more data from more sources.

“We’re speeding up growth in the insurance, clinical trials, and health plans markets, as well as new use cases like COVID-19 screening.”

To support its growth ambitions, the company has named Richard Dufty as its new chief commercial officer. Dufty previously supported the growth of AppDirect from early stage startup to Unicorn status in just 4 years.

Human API provides consumers with a streamlined was of accessing and sharing their health records. People have full control of their health data, with the platform connecting, managing and sharing data from electronic health records, pharmacies, labs, wearables and fitness apps.

By sharing this information, insurance firms can improve their underwriting and claims processes.

Pop added, “On our platform, you can easily and instantly give a digital health provider the consent and data they need to deliver you personalized care. Or, through a couple of easy steps, you could immediately enlist as part of a pharma company’s new clinical trial. Or, even, if you’re in need of life insurance, but COVID-19 prevents an in-person assessment, you can instantly send what’s required via our platform, completing the underwriting process in 24 hours.”

Copyright © 2020 AltAssets

Get the latest PE News & Research delivered to your inbox every morning